EichorEICHOR
Condition: Urinary Bladder Diseases Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Urinary Bladder Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder
NA · 1 location(s) · LifeBiotic Medical Research Ltd. · NCT07728474Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT07379255Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients
NA · 1 location(s) · The General Hospital of Western Theater Command · NCT06599346Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
NA · 4 location(s) · Aalborg University Hospital · NCT05989646Hospital at Home for Elderly Acute Ill Patients
NA · 3 location(s) · Defactum, Central Denmark Region · NCT05360914Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT06025734Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00026884A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06735287Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05772637Antibiotic Usage Prior to OnabotulinumtoxinA Injection
NA · 1 location(s) · Benaroya Research Institute · NCT04754737Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms
Phase N/A · 1 location(s) · Medstar Health Research Institute · NCT07390591Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
EARLY_Phase 1 · 4 location(s) · Hackensack Meridian Health · NCT05657990Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer
Phase 2 · 3 location(s) · Queen Mary University of London · NCT06892860Bladder EpiCheck Product Development Study
Phase N/A · 2 location(s) · Nucleix Ltd. · NCT07514143Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · 163 location(s) · Bristol-Myers Squibb · NCT07106762SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Phase 1/Phase 2 · 2 location(s) · University of Arizona · NCT06814496A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Phase N/A · 1 location(s) · Yingbin Liu, MD, PhD, FACS · NCT07176962Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Uro
Phase 1/Phase 2 · 8 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06364956Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Pati
Phase 2 · 2 location(s) · University of Kansas Medical Center · NCT06493370Study of Bladder-sphincter Symptoms in Functional Neurological Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05689866Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05126472Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05878964Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05415631Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Tre
Phase 4 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT07474519Integrated Cancer Repository for Cancer Research
Phase N/A · 42 location(s) · University of Nebraska · NCT02012699Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unr
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06852287An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With
Phase 3 · 160 location(s) · AstraZeneca · NCT07720284Feasibility of Triggered Sacral Neuromodulation for Neurogenic Bladder
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT05141487Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Phase 1 · 4 location(s) · Novartis Pharmaceuticals · NCT07660055
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.